GlassScriptPhysician profile
Catherine Tuong
NPI 1477993723
$3,133.12
in general payments reported to CMS, 2019-2025
13 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $34.96 · 2021: $367 · 2022: $910 · 2023: $799 · 2024: $652 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,821.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,007.20 | 2022-2025 | Miebo, Infuse, Vyzulta |
| Sun Pharmaceutical Industries INC. | $371.91 | 2022-2023 | Cequa |
| Johnson & Johnson Vision Care, INC. | $295.32 | 2023-2024 | Acuvue |
| Alcon Vision LLC | $276.94 | 2020-2022 | |
| Allergan, INC. | $257.30 | 2021-2022 | |
| Sight Sciences, INC. | $164.38 | 2022-2023 | Tearcare System |
| Coopervision INC. | $135.35 | 2023 | Misight Contact Lens |
| Horizon Therapeutics Plc | $125.00 | 2023 | Tepezza |
| Oyster Point Pharma, INC. | $125.00 | 2024 | Tyrvaya |
| Dompe US, INC. | $120.86 | 2024 | Oxervate |
| Kala Pharmaceuticals, INC. | $120.45 | 2021 | |
| Aerie Pharmaceuticals, INC. | $114.01 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Tuong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.